VENTRICULAR FAILURE side effect
What is VENTRICULAR FAILURE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
VENTRICULAR FAILURE and Recently Reported Side Effects
VENTRICULAR FAILURE and 15 most Active Side Effect polls
VENTRICULAR FAILURE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Novoseven Side Effects Report #5625832-3
Physician from BRAZIL reported NOVOSEVEN problem on Feb 11, 2008. Female patient was diagnosed with surgery and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: ventricular failure, . NOVOSEVEN dosage: unknown. Patient died.
Mabthera Side Effects Report #5715313-0
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2008. Female patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: ventricular failure, . MABTHERA dosage: unknown. During the same period patient was treated with LEFLUNOMIDE. Patient recovered.
Zoledronic Side Effects Report #5441308-0
Physician from POLAND reported ZOLEDRONIC ACID problem on Aug 20, 2007. Female patient, 69 years of age, weighting 127.9 lb, was diagnosed with osteoporosis postmenopausal, coronary artery disease, cardiac failure, prophylaxis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, electrocardiogram t wave inversion, ventricular failure, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with CALCIUM SANDOZ, VITAMIN D3, ATENOLOL, INHIBACE, SPIRONOL, BEMECOR, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5787455-5
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2008. Male patient, weighting 197.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, ventricular dysfunction, ventricular failure, . DAUNORUBICIN dosage: 291 MG. Patient recovered.